I-mab American Depositary Shares Stock Insider Power
Based on the 82 latest insides trades, we have calculated the insider power to be positive at 98.55. In total, the insiders bought 16.15M and sold 49.99K NBP shares in the last 82 trades. The insider score can be negative despite buy/sell ratio being positive. The score focuses on the quality of the trades.
Insider Power
|
98.55 |
| ● Buy | 16.15M shares |
| ● Sell | 49.99K shares |
|
88% Buy Activity
Strong Negative Correlation
|
|
No Significant SignalsNo statistically significant buy or sell signals detected in recent insider data. |
|
Historical Insider Trades
| Date | Type | Person | Role | Amount |
|---|---|---|---|---|
|
Jul 08, 2026 Buy |
Lin Liwei Lorraine General Counsel |
254 780 Value: $491.7K |
||
|
Jul 08, 2026 Buy |
Hagler Mark Arnold Chief Commercial Officer |
949 050 Value: $1.83M |
||
|
Jul 06, 2026 Buy |
Gupta Srishti Chief Executive Officer |
3 000 000 Value: $6.03M |
||
|
Jul 06, 2026 Sell |
Xu Cong Claire SVP, Clinical Development |
4 485 Value: $4K |
||
|
Jul 04, 2026 Buy |
Xu Cong Claire SVP, Clinical Development |
5 405 Value: $10K |
||
|
Jul 04, 2026 Buy |
Xu Cong Claire SVP, Clinical Development |
12 432 Value: $22.0K |
||
|
Jul 01, 2026 Buy |
Gupta Srishti Insider |
0 Value: $0 |
||
|
Jun 29, 2026 Buy |
Fu Wei Director |
725 140 Value: $1.78M |
||
|
Jun 29, 2026 Buy |
Fu Wei Director |
1 010 100 Value: $2.00M |
||
|
Jun 29, 2026 Buy |
Fu Wei Director |
1 087 720 Value: $2.66M |
||
|
Jun 22, 2026 Buy |
Cao Sean Wuxiong Chief Bus. Development Officer |
181 280 Value: $277.4K |
||
|
Jun 22, 2026 Buy |
Cao Sean Wuxiong Chief Bus. Development Officer |
181 290 Value: $277.4K |
||
|
Jun 18, 2026 Sell |
Dennis Phillip Andrew Chief Medical Officer |
8 494 Value: $6K |
||
|
Jun 17, 2026 Buy |
Dennis Phillip Andrew Chief Medical Officer |
10 302 Value: $16.2K |
||
|
Jun 17, 2026 Buy |
Dennis Phillip Andrew Chief Medical Officer |
23 695 Value: $37.2K |
||
|
Jun 01, 2026 Sell |
Xu Cong Claire SVP, Clinical Development |
3 494 Value: $13.8K |
||
|
May 30, 2026 Buy |
Xu Cong Claire SVP, Clinical Development |
4 079 Value: $7K |
||
|
May 30, 2026 Buy |
Xu Cong Claire SVP, Clinical Development |
9 382 Value: $16.6K |
||
|
May 14, 2026 Sell |
Cao Sean Wuxiong See Remarks |
21 399 Value: $42.6K |
||
|
Apr 24, 2026 Buy |
Hagler Mark Arnold See Remarks |
230 000 Value: $577.3K |
||
|
Apr 17, 2026 Buy |
Hagler Mark Arnold Insider |
0 Value: $0 |
||
|
Mar 18, 2026 Buy |
Xu Cong Claire See Remarks |
0 Value: $0 |
||
|
Mar 18, 2026 Buy |
Yang Conor Chia-hung Director |
34 530 Value: $133.3K |
||
|
Mar 18, 2026 Buy |
Yang Conor Chia-hung Director |
114 093 Value: $139.2K |
||
|
Mar 18, 2026 Buy |
Chu Denny Hsueh Wen Insider |
0 Value: $0 |
About Insider Power
Insider Power is a proprietary algorithm developed by StockInvest.us to evaluate the significance of insider transactions. The calculation considers the size, type, and timing of transactions, as well as the insider’s role within the company.
It is important to note that, in general, there is little to no correlation between insider transactions and short-term stock price movements. In one of our studies, only 0.22%* of stocks with insider activity showed a measurable correlation — and even then, it was unclear whether the effect was caused by insider actions or simply by the stock’s broader trend.
While our algorithms are designed to highlight potentially meaningful signals, these cannot be regarded as statistically significant on their own. Insider trading activity should therefore be seen as informative rather than as direct trading guidance. The Insider Power metric was created to present this information in a clearer and more accessible way, helping investors better understand the possible context of insider activity.
* October 6th, 2025 - Tested on 5562 stocks
Sign In
Buy NBP